| Literature DB >> 10021917 |
D E Zembower1, H Zhang, J P Lineswala, M J Kuffel, S A Aytes, M M Ames.
Abstract
All four "symmetrical" regioisomers of ED-110, an indolocarbazole derivative having potent activity against human topoisomerase I (Topo I) were synthesized. The isomer containing hydroxyl groups in the 3- and 9-positions was approximately ten-fold more active against Topo I, and 5- to 35-fold more active against human solid tumor cell lines in vitro, relative to ED-110.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10021917 DOI: 10.1016/s0960-894x(98)00710-0
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823